IMC Chicago’s Patterson-UTI PTEN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$1.31M Sell
121,300
-66,500
-35% -$569K ﹤0.01% 2996
2025
Q4
$1.15M Buy
187,800
+141,600
+306% +$845K ﹤0.01% 2868
2025
Q3
$239K Sell
46,200
-11,900
-20% -$68.4K ﹤0.01% 3495
2025
Q2
$345K Sell
58,100
-400
-0.7% -$2.41K ﹤0.01% 3051
2025
Q1
$481K Sell
58,500
-19,100
-25% -$160K ﹤0.01% 2680
2024
Q4
$641K Buy
77,600
+16,100
+26% +$129K ﹤0.01% 2619
2024
Q3
$470K Buy
61,500
+8,900
+17% +$82K ﹤0.01% 2442
2024
Q2
$545K Buy
+52,600
New +$577K ﹤0.01% 2259

Other funds holding PTEN

IMC Chicago's PTEN Position: Q4 2025 in Review

IMC Chicago sold out of Patterson-UTI (PTEN) in Q4 2025, closing a stake of 74,394 shares — an estimated $444K sold.

IMC Chicago first reported a position in PTEN in Q1 2025 and held it in 3 quarters. The position peaked at $385K in Q3 2025. 372 funds tracked by Wall St. Rank hold PTEN as of Q4 2025.

  • IMC Chicago reported no remaining Patterson-UTI position as of Q4 2025 after selling out during the quarter.
  • IMC Chicago sold 74,394 Patterson-UTI shares in Q4 2025, an estimated $444K.
  • IMC Chicago first reported a position in Patterson-UTI in Q1 2025 and held it in 3 quarters.
  • IMC Chicago's Patterson-UTI position peaked at $385K in Q3 2025.
  • 372 funds tracked by Wall St. Rank held Patterson-UTI as of Q4 2025.

Based on IMC Chicago's 13F filing for Q4 2025, filed 29 Jan 2026.